/DISREGARD RELEASE: Aevolve/
We are advised by a representative of the company that journalists and other readers should disregard the news release, Patients and Investors Now Have an Opportunity to Support Medical Innovation Through AEVOLVE, AG & FP Issuer, Ltd., issued Nov. 7, 2019 over PR Newswire, as it contained some erroneous information.
SOURCE Aevolve
Upcoming Life Sciences Events
- April 2024
- Pharma-Biotech Product & Company Valuation - An Introductory
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024